BES, EES, and ZES-R in Real World Practice
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 1960 participants.
Also called NCT01397175
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,960 participants
- Sponsor
- Registry
-
NCT01397175
-
- Other papers using this trial's data
- Randomized Comparison of Everolimus- and Zotarolimus-Eluting Coronary Stents With Biolimus-Eluting Stents in All-Comer Patients
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Terminated
Technical summary
Registry record NCT01397175. Randomized; single masking; primary purpose treatment. Start 2013-01-16 (actual); primary completion 2017-12-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BES, EES, and ZES-R in Real World Practice
- Acronym
- CHOICE
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Biolimus-eluting stent
- Intervention (Device)
- Everolimus-eluting stent
- Intervention (Device)
- Zotarolimus-eluting stent
- Lead sponsor
- Yonsei University
- Collaborator
- Gangwon Cardiovascular Health Research Institute
Record details
- Record id
cardio:ct-nct01397175- Content hash
bcdbe78659cca5271b1d7021e73ae2e27fa9fbe17cc3feca448478202a11613b